Delivery Order SPE2DE21D0005-SPE2D625F35N5

Award Date 12/3/24
Potential Completion Date 12/6/24
Potential Value $1.2K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DE21D0005
    Indefinite Delivery Contract
  • SPE2DE21D0005-SPE2D625F35N5
    Delivery Order

This federal contract award to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts, is a $1,239.95 Delivery Order (SPE2DE21D0005|SPE2D625F35N5) placed by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of APLIGRAF, an advanced wound care product.

The award is not associated with a set-aside program and is a Fixed Price with Economic Price Adjustment contract type. Organogenesis has a strong track record of providing regenerative medicine solutions to federal healthcare agencies, including the Department of Defense (DoD) and Department of Veterans Affairs (VA). The company holds several significant federal Indefinite Delivery Vehicles (IDVs) worth up to $49.5 million for wound care dressings, surgical implants, and tissue regeneration products. This latest award supports the agency's ongoing medical supply chain needs, particularly for products designed to aid wound healing and tissue regeneration for service members and veterans.

Generated 3/4/25, 11:37 AM